Brief: Cancer Genetics Posts Q2 Loss Per Share Of $0.01

Vyant Bio

20/08/2019 13:14

Aug 20 (Reuters) - Cancer Genetics Inc  CGIX.O :
    * CANCER GENETICS REPORTS SECOND QUARTER 2019 FINANCIAL
RESULTS
AND PROVIDES STRATEGIC BUSINESS UPDATE
    * Q2 LOSS PER SHARE $0.01
    * QUARTERLY REVENUE$1.5 MILLION VERSUS $1.3 MILLION
    * CASH AND CASH EQUIVALENTS AS OF JUNE 30, 2019 TOTALED $0.7
MILLION, COMPARED TO $0.2 MILLION AS OF DECEMBER 31, 2018.

Source text for Eikon:  ID:nGNX8rMz3 
Further company coverage:  CGIX.O 

 ((Reuters.Briefs@thomsonreuters.com;))